ALA / PDT therapy branches toward benign skin tumors

New Orleans - With a brief yet successful track record of treatingmalignant and pre-malignant skin conditions, 5-aminolevulinic acid (ALA)in combination with photodynamic therapy (PDT) could soon become an effectivealternative for benign cutaneous tumors such as sebaceous hyperplasia, seborrheickeratoses, and plantar warts.

Related Videos
Related Content

Silybum Marianum Fruit Extract Safe, Effective in Acne-Prone Skin

March 29th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

EON Gains FDA Clearance for Back and Thighs

March 29th 2023

The Cutaneous Connection: JAK Inhibitor Safety for Treating AD

December 14th 2022

Iovance Completes Biologics License Application (BLA) Submission for Advanced Melanoma Drug

March 28th 2023

Breast Care for Pregnant and Lactating Patients

March 28th 2023

Silybum Marianum Fruit Extract Safe, Effective in Acne-Prone Skin

March 29th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

EON Gains FDA Clearance for Back and Thighs

March 29th 2023

The Cutaneous Connection: JAK Inhibitor Safety for Treating AD

December 14th 2022

Iovance Completes Biologics License Application (BLA) Submission for Advanced Melanoma Drug

March 28th 2023

Breast Care for Pregnant and Lactating Patients

March 28th 2023

Silybum Marianum Fruit Extract Safe, Effective in Acne-Prone Skin

March 29th 2023

The Cutaneous Connection: Managing Atopic Dermatitis With Emerging Techniques

March 9th 2023

EON Gains FDA Clearance for Back and Thighs

March 29th 2023

The Cutaneous Connection: JAK Inhibitor Safety for Treating AD

December 14th 2022

Iovance Completes Biologics License Application (BLA) Submission for Advanced Melanoma Drug

March 28th 2023

Breast Care for Pregnant and Lactating Patients

March 28th 2023
© 2023 MJH Life Sciences

All rights reserved.